Does DABIGATRAN ETEXILATE Cause Rectal haemorrhage? 964 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 964 reports of Rectal haemorrhage have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 2.6% of all adverse event reports for DABIGATRAN ETEXILATE.
964
Reports of Rectal haemorrhage with DABIGATRAN ETEXILATE
2.6%
of all DABIGATRAN ETEXILATE reports
200
Deaths
751
Hospitalizations
How Dangerous Is Rectal haemorrhage From DABIGATRAN ETEXILATE?
Of the 964 reports, 200 (20.7%) resulted in death, 751 (77.9%) required hospitalization, and 78 (8.1%) were considered life-threatening.
Is Rectal haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 964 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
Atrial fibrillation (858)
What Other Drugs Cause Rectal haemorrhage?
RIVAROXABAN (4,501)
ASPIRIN (3,057)
ADALIMUMAB (2,629)
VEDOLIZUMAB (2,163)
INFLIXIMAB (1,554)
CLOPIDOGREL BISULFATE (1,333)
APIXABAN (1,177)
WARFARIN (1,174)
PREDNISONE (1,098)
MESALAMINE (990)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Rectal haemorrhage Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB